AVALON™ Grand Plus Specifications

AVALON™ Grand Plus is a non-surgical filler that contains highly purified hyaluronic acid (24 mg/ml) and lidocaine (0.3%) for numbing effects. It is designed to be injected into the deep dermis for the correction of moderate to severe facial wrinkles and folds, cheeks, chin augmentation, and modeling of the contours of the face and jawline. AVALON™ Grand Plus Viscous Filler is an ideal solution for correcting thick skin and deep wrinkles and is also effective in restoring volume with results that last 12-18 months*. *The duration of effect may vary depending on the individual physical characteristics of the patient, the method of injection and the type of procedure. Cross-linked hyaluronic acid in AVALON™ fillers MCO™ technology. (Minimization of crosslinking agent by optimized reaction technology) is a technology developed by the R&D Institute of Koru Pharmaceuticals. The crosslinking agent serves to connect chains of hyaluronic acid to form a network. By optimizing the crosslinking reaction conditions in which a chemical reaction between the crosslinking agent and HA occurs, the use of the crosslinking agent is minimized, thus maximizing the efficiency of the crosslinking reaction. [/vc_column_text]